Abstract
OBJECTIVE: We sought to assess the efficacy of a clinical protocol to reduce the incidence of early-onset neonatal group B Streptococcus (GBS) infection. STUDY DESIGN: We assessed neonatal sepsis from GBS and other organisms with use of a before-after study design to evaluate the effects of implementation of combined intrapartum antimicrobial prophylaxis given selectively to mothers with GBS risks and penicillin G given to all neonates. RESULTS: In 1994, early-onset GBS infection developed in 31 of 13,887 live births (2.2/1000), 13 preterm and 18 term cases. After implementation of the prophylaxis protocol (1995), 6 of 13,527 live births had early-onset GBS (0.4/1000) (P < .001). There were no preterm (P = .0004) and 6 term GBS cases (P = .02). The efficacy continued through 1999 (0.5/1000) without an increase in neonatal infections from other bacteria. CONCLUSION: Combined maternal and infant antimicrobial prophylaxis can significantly and safely reduce rates of early-onset GBS infection in both preterm and term infants.
Original language | English (US) |
---|---|
Pages (from-to) | 618-626 |
Number of pages | 9 |
Journal | American journal of obstetrics and gynecology |
Volume | 186 |
Issue number | 4 |
DOIs | |
State | Published - 2002 |
Keywords
- Ampicillin
- Group B Streptococcus
- Neonatal sepsis
- Penicillin G
ASJC Scopus subject areas
- Obstetrics and Gynecology